NF-κB p65 is a ubiquitously expressed transcription factor that is a subunit of the NF-κB complex and is encoded by the RELA gene in humans.1 It is composed of an N-terminal Rel homology domain, which mediates dimerization, nuclear localization, and DNA and protein interactions, and two C-terminal transactivation domains that are subject to a variety of post-translational modifications and regulate the transcriptional activity of p65.1,2 NF-κB p65 regulates the expression of a large number of genes in response to inflammatory and environmental cues that play critical roles in innate and adaptive immunity and cellular differentiation.2 Genome-wide deletion of Rela in mice is embryonic lethal.3 Silencing of NF-κB p65 induces tumor cell apoptosis in a murine Lewis lung carcinoma model and decreases secreted levels of IL-1β and TNF-α induced by LPS in THP-1 monocytes.4,5 NF-κB p65 is overexpressed in inflamed joints of patients with rheumatoid arthritis, and naïve CD4 T cells isolated from the whole blood of patients with multiple sclerosis have increased phosphorylation of NF-κB p65.6,7 Cayman's NF-κB p65 (human, recombinant) protein can be used for Western blot and ELISA applications. Cayman’s NF-κB (p65) Polyclonal Antibody can be used for ELISA and Western blot applications. The antibody recognizes NF-κB at 65 kDa from human samples.WARNING This product is not for human or veterinary use.
